Dexamethasone premedication suppresses vaccine-induced immune responses against cancer

Glucocorticosteroids (GCS) have an established role in oncology and are administered to cancer patients in routine clinical care and in drug development trials as co-medication. Given their strong immune-suppressive activity, GCS may interfere with immune-oncology drugs. We are developing a therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Vormehr, Mathias, Lehar, Sophie, Kranz, Lena M., Tahtinen, Siri, Oei, Yoko, Javinal, Vincent, Delamarre, Lélia, Walzer, Kerstin C., Diken, Mustafa, Kreiter, Sebastian, Mellman, Ira, Sahin, Ugur, Schartner, Jill M., Türeci, Özlem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458619/
https://www.ncbi.nlm.nih.gov/pubmed/32923115
http://dx.doi.org/10.1080/2162402X.2020.1758004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458619/
https://www.ncbi.nlm.nih.gov/pubmed/32923115
http://dx.doi.org/10.1080/2162402X.2020.1758004

Ejemplares similares